Viewing Study NCT03508258


Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2025-12-25 @ 10:21 PM
Study NCT ID: NCT03508258
Status: WITHDRAWN
Last Update Posted: 2022-06-30
First Post: 2018-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
Sponsor: Bristol-Myers Squibb
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-09-01
Start Date Type: ACTUAL
Primary Completion Date: 2018-09-01
Primary Completion Date Type: ACTUAL
Completion Date: 2018-09-01
Completion Date Type: ACTUAL
First Submit Date: 2018-04-16
First Submit QC Date: None
Study First Post Date: 2018-04-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-06-28
Last Update Post Date: 2022-06-30
Last Update Post Date Type: ACTUAL